HIGH-THROUGHPUT DRUG SCREENING IDENTIFIES HDAC INHIBITORS AS CANDIDATE THERAPEUTICS FOR MYC-DRIVEN MEDULLOBLASTOMA

BACKGROUND: Medulloblastoma (MB) is a highly malignant pediatric brain tumor. Despite aggressive therapy, many patients succumb to the disease, and survivors experience severe side effects from treatment. MBs with high levels of the MYC oncogene have a particularly poor prognosis, and would benefit...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Wechsler-Reya, Robert J., Pei, Yanxin, Liu, Kun-Wei, Wang, Jun, Esparza, Lourdes A., Maier, Donna L., Li, Xiao-Nan, Cho, Yoon-Jae
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2014
Témata:
abstracts
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4144567/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou208.22
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky